• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Neuronetics, Inc. - Common Stock (NQ:STIM)

    1.560 -0.110 (-6.59%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,115,463
    Open 1.670
    Bid (Size) 1.530 (7,000)
    Ask (Size) 1.600 (1,000)
    Prev. Close 1.670
    Today's Range 1.560 - 1.690
    52wk Range 0.8000 - 4.849
    Shares Outstanding 66,113,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Neuronetics Highlights Continued Advancements in TMS Research at CTMSS 2026
    New findings from the industry’s largest real-world TMS database reinforce NeuroStar’s leadership in advancing evidence-based mental health care 
    From Neuronetics
    Via GlobeNewswire
    News headline image
    Neuronetics and ANT Neuro Announce Strategic Collaboration to Integrate Neuronavigation with NeuroStar TMS Treatment
    First-of-its-kind partnership expands NeuroStar platform capabilities with advanced visualization technology designed to address evolving provider needs and support more personalized treatment... 
    From Neuronetics
    Via GlobeNewswire

    Performance

    YTD
    +8.3%
    +8.3%
    1 Month
    -22.8%
    -22.8%
    3 Month
    +20.9%
    +20.9%
    6 Month
    +9.5%
    +9.5%
    1 Year
    -59.1%
    -59.1%

    More News

    Read More
    News headline image
    Neuronetics (STIM) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    Neuronetics Inc (NASDAQ:STIM) Posts Narrower Loss in Q1 2026, Pre-Market Rises Despite Revenue Miss ↗
    Via Chartmill
    NEURONETICS INC (NASDAQ:STIM) Reports Q4 Revenue Beat but Shares Drop on Cautious Outlook ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Earnings Scheduled For August 5, 2025 ↗
    Via Benzinga
    News headline image
    Optum/United Healthcare/United Behavioral Health Expands NeuroStar® TMS Coverage to Include Psychiatric Mental Health Nurse Practitioners
    From Neuronetics
    Via GlobeNewswire
    News headline image
    Neuronetics (STIM) Q4 2025 Earnings Transcript ↗
    Via The Motley Fool
    Which stocks are experiencing notable movement on Wednesday? ↗
    Via Chartmill
    Top stock movements in today's session. ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
    Via Chartmill
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Top 3 Health Care Stocks Which Could Rescue Your Portfolio In November ↗
    Via Benzinga
    News headline image
    TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression
    From Neuronetics
    Via GlobeNewswire
    News headline image
    Tuesday's pre-market session: top gainers and losers ↗
    Via Chartmill
    News headline image
    NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss ↗
    Via Chartmill
    News headline image
    Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence
    From Neuronetics
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)
    From Neuronetics
    Via GlobeNewswire
    News headline image
    Neuronetics Inc (NASDAQ:STIM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider-Than-Expected Loss ↗
    Via Chartmill
    News headline image
    NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents
    From Neuronetics
    Via GlobeNewswire
    News headline image
    Neuronetics Announces Clinical Presence at the 2025 Clinical TMS Society Annual Meeting and Progress in Greenbrook’s Personalized Care Trial Program
    From Neuronetics
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Neuronetics, Inc. - Common Stock publicly traded?
    Yes, Neuronetics, Inc. - Common Stock is publicly traded.
    What exchange does Neuronetics, Inc. - Common Stock trade on?
    Neuronetics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Neuronetics, Inc. - Common Stock?
    The ticker symbol for Neuronetics, Inc. - Common Stock is STIM on the Nasdaq Stock Market
    What is the current price of Neuronetics, Inc. - Common Stock?
    The current price of Neuronetics, Inc. - Common Stock is 1.560
    When was Neuronetics, Inc. - Common Stock last traded?
    The last trade of Neuronetics, Inc. - Common Stock was at 06/02/26 04:00 PM ET
    What is the market capitalization of Neuronetics, Inc. - Common Stock?
    The market capitalization of Neuronetics, Inc. - Common Stock is 103.14M
    How many shares of Neuronetics, Inc. - Common Stock are outstanding?
    Neuronetics, Inc. - Common Stock has 103M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.